NCT03730974

Brief Summary

The objective of the study is to examine the efficacy of Protac Ball BlanketsTM (PBB) and specifically if the PBB will extend the total sleep time of patients with insomnia due to depression in two psychiatric outpatient clinics at Aarhus University Hospital and Odense University Hospital. Furthermore, it will be examined whether the PBB will reduce the sleep onset latency, number of awakenings, wake after sleep onset, need for sedatives and hypnotics, the self reported symptoms of depression and anxiety and improve the quality of sleep. 45 patients with depression and insomnia who receive outpatient treatment will be included in this study. The study is a randomized crossover trial. The data collection period lasts four weeks. Data will be collected using actigraphy, sleep diaries and questionnaires.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
45

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 2, 2018

Completed
4 months until next milestone

First Posted

Study publicly available on registry

November 5, 2018

Completed
1 year until next milestone

Study Start

First participant enrolled

November 21, 2019

Completed
3.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2023

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2023

Completed
Last Updated

May 23, 2022

Status Verified

May 1, 2022

Enrollment Period

3.5 years

First QC Date

July 2, 2018

Last Update Submit

May 20, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Changes in total night time sleep (TST) measured by actigraphy (Micro MotionLogger Watch)

    The investigators will detect the change in total night time sleep in minutes (actual sleep time, excluding sleep latency and wakes after sleep onset) by comparing the means of the difference in TST for each participant between period A and B or B and A

    Four weeks

Secondary Outcomes (10)

  • Changes in sleep onset latency (SOL)

    Four weeks

  • Changes in number of awakenings measured by actigraphy (Micro MotionLogger Watch)

    Four weeks

  • Sedatives and hypnotics measured by medication registration use in sleep diaries

    Four weeks

  • Quality of sleep measured by questionnaire using the Pittsburgh Sleep Quality Index

    Data will be collected at baseline, after two weeks and after four weeks. The difference between PSQI measured at week 2 and week 0 will be compared with the difference in PSQI measured at week 4 and week 2.

  • Symptoms of depression measured by the self-reported Hamilton Depression Rating Scale (HRSD6)

    Data will be collected at baseline, after two weeks and after four weeks. The difference between the score measured at week 2 and week 0 will be compared with the difference in score measured at week 4 and week 2.

  • +5 more secondary outcomes

Study Arms (2)

Experimental arm AB (Ball blanket + TAU)

EXPERIMENTAL

Participants will be randomized into either sequence AB or BA each lasting four weeks. Patients that are randomized to the AB sequence receive intervention A (Protac Ball BlanketTM 7 kg Flexible) in the first two weeks and treatment B treatment as usual (TAU) in the second period.

Device: Protac Ball BlanketTM (7kg Flexible)

Experimental arm BA (TAU + Ball blanket)

EXPERIMENTAL

Patients that are randomized to the BA sequence receive treatment B (TAU) in the first period and intervention A in the second period (Protac Ball BlanketTM 7kg Flexible).

Device: Protac Ball BlanketTM (7kg Flexible)

Interventions

All patients will wear a MotionLogger Micro Watch from Ambulatory Monitoring Inc. NY in all four weeks during all 24hours of the day.

Also known as: MotionLogger Micro Watch from Ambulatory Monitoring Inc. NY
Experimental arm AB (Ball blanket + TAU)Experimental arm BA (TAU + Ball blanket)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Participants: Patients with depression according to ICD-10 (F32-33) or (F32-33 in combination with F40-41.2) (males and females, aged ≥18 years) who receive outpatient treatment in The Mood Disorders Clinic, Aarhus University Hospital, Risskov, Denmark and in The Clinic of Affective Disorders, Department of Psychiatry, Psychiatry in The Region of Southern Denmark.
  • Participants must either experience poor sleep quality, sleep onset latency or wake time after sleep onset of: (a) ≥31 min; (b) occurring ≥3 nights a week; (c) for ≥ 14 days (31) or early wake ups, and have a Global Pittsburgh Sleep Quality Index Score ≥5.

You may not qualify if:

  • Patients that, according to ICD-10 criteria, have been depressed \>2 years
  • Patients suffering from hypersomnia (ICD-10: F51.13)
  • Patients with current alcohol- or drug abuse (ICD-10: F10-19)
  • Patients with diseases directly influencing sleep quality (such as severe chronic pain issues, sleep apnoea o.a.)
  • Patients receiving medications causing sleep loss and disturbed sleep
  • Patients with Circadian Rhythm Sleep-Wake Disorders (ICD-10; G47.20-47.26)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

The Mood Disorders Clinic

Aarhus, Central Danish Region, 8200, Denmark

RECRUITING

Mental Health Department Odense - University Clinic

Odense, Region Syddanmark, 5000, Denmark

RECRUITING

Related Publications (1)

  • Kristiansen ST, Videbech P, Bjerrum MB, Larsen ER. The efficacy of ball blankets on insomnia in depression in outpatient clinics: study protocol for a randomized crossover multicentre trial. Trials. 2020 Aug 17;21(1):720. doi: 10.1186/s13063-020-04638-y.

Study Officials

  • Erik R Larsen, MD PhD

    Odense University Hospital

    STUDY DIRECTOR

Central Study Contacts

Sanne T Kristiansen, RN,MCN

CONTACT

Erik R Larsen, MD PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: The study has a randomized 2-sequence, 2-period, 2-treatment crossover design.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 2, 2018

First Posted

November 5, 2018

Study Start

November 21, 2019

Primary Completion

June 1, 2023

Study Completion

November 30, 2023

Last Updated

May 23, 2022

Record last verified: 2022-05

Data Sharing

IPD Sharing
Will not share

Locations